Day: May 6, 2024

Allot Announces the Appointment of Eyal Harari as Chief Executive Officer

Written by Customer Service on May 6, 2024. Posted in Public Companies.

Hod Hasharon, Israel, May 06, 2024 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, today announced the appointment of Eyal Harari as its Chief Executive Officer effective May 6, 2024. He will be replacing Mr. Erez Antebi. At the request of the company’s Board of Directors, Mr. Antebi has agreed to assist Mr. Harari during a transition period and thereafter, to continue to provide consulting services to the company. “We are extremely pleased that Eyal is joining Allot as Chief Executive Officer. He brings his vast experience, management and business skills in fields that are synergetic to Allot’s business markets. We would like to thank Erez for his seven and a half years...

SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors

Written by Customer Service on May 6, 2024. Posted in Public Companies.

MIAMI, May 06, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announced that Jay Skyler, MD, MACP, FRCP has been appointed to the company’s Board of Directors. “Dr. Skyler’s appointment to our Board of Directors is a major milestone for SAB,” said Samuel J. Reich, SAB’s chairman and Chief Executive Officer. “His deep expertise in type 1 diabetes research and leadership in the field will provide insights that will be invaluable to our SAB-142 program. Speaking on behalf of the Board, we are honored to add Dr. Skyler to the Board of Directors and look forward to his contributions as we continue...

Flow Capital Announces Repayment of USD 4.5 Million Investment

Written by Customer Service on May 6, 2024. Posted in Public Companies.

TORONTO, May 06, 2024 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital”), a leading provider of flexible growth capital solutions, is pleased to announce the full repayment of a USD 4.5 million investment in an environmental solutions provider. Flow Capital continues to focus on providing flexible growth financing solutions to small and mid-cap high-growth companies across multiple sectors. With the help of our capital, companies are better able to execute their growth plans, scale their operations more aggressively, or seize unique opportunities, all while avoiding excessively dilutive financing or restrictive equity-based relationships. The capital returned from this investment will be reinvested into new opportunities, in pursuit of interest income and warrant based equity gains, creating more value...

N2OFF: Save Foods to Target California’s Hemp Market

Written by Customer Service on May 6, 2024. Posted in Public Companies.

More than half of US hemp flower grown in California recently received Pre-Harvest Regulatory Approval in California allowing Save Foods to treat hemp Neve Yarak, Israel, May 06, 2024 (GLOBE NEWSWIRE) — N2OFF, Inc. (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant-based food, announced today that its subsidiary Save Foods Ltd. (“Save Foods”) is set to target the hemp flower market in California. The Company recently announced that the California Department of Pesticide Regulation approved and registered the use of Save Foods’ pre-harvest treatment, FieldProtect, based on compliance with provisions of California laws and regulations pertaining to pesticide registration. Hemp flowers are usually treated before harvesting, the new approval...

Skyward Specialty Announces Secondary Offering of Its Common Stock

Written by Customer Service on May 6, 2024. Posted in Public Companies.

HOUSTON, May 06, 2024 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) (“Skyward Specialty” or the “Company”) a leader in the specialty property and casualty (“P&C”) market, announced that The Westaim Corporation (“Westaim”), through its wholly-owned subsidiary, Westaim HIIG GP Inc. (the “Selling Stockholder”) is offering 4,400,000 shares of the Company’s common stock in an underwritten secondary public offering. In connection with the offering, the Selling Stockholder has also granted the underwriters a 30-day option to purchase up to an additional 660,000 shares of Skyward Specialty’s common stock. The Selling Stockholder will be a 4.80% and 6.45% shareholder in Skyward Specialty, assuming full and no exercise of the underwriters’ option to purchase the additional shares, respectively. Skyward...

Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America

Written by Customer Service on May 6, 2024. Posted in Public Companies.

Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South AmericaAchieves No. 1 spot with a record 26% market share in Middle East & Africa, led by strong performance in Algeria with the FIAT Professional brand Confirms market leadership in Europe 30 and South America North America plays a key role in Pro One success; Ram announces new professional commercial vehicle division Stellantis Pro One on track to global leadership by 2027; achieve Dare Forward 2030 targetAMSTERDAM, May 6, 2024 – Demonstrating its market leadership in the Middle East and Africa region for the second quarter in a row, the Stellantis Pro One commercial vehicles offensive delivered an excellent performance in the first quarter of 2024, accounting for one-third of Net revenues...

Freshpet, Inc. Reports First Quarter 2024 Financial Results

Written by Customer Service on May 6, 2024. Posted in Earnings Releases And Operating Results.

Company Updates 2024 Outlook; Raises Adjusted EBITDA GuidanceNet Sales Driven by Volume-Based Growth Profitability Improvement Driven by Lower Input, Quality and Logistics Costs SECAUCUS, N.J., May 06, 2024 (GLOBE NEWSWIRE) — Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today reported financial results for its first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Compared to Prior Year PeriodNet sales of $223.8 million, an increase of 33.6%. Gross margin of 39.4%, compared to the prior year period of 30.3%. Adjusted Gross Margin of 45.3%, compared to the prior year period of 38.5%. Net income of $18.6 million, compared to the prior year period net loss of $24.8 million. Adjusted EBITDA of $30.6 million, compared to the prior year period of $3.0 million.1“Our strong first quarter results...

Verkkokauppa.com Oyj: Jesper Blomster appointed as new CFO and member of the management team in Verkkokauppa.com Oyj

Written by Customer Service on May 6, 2024. Posted in Public Companies.

Verkkokauppa.com Oyj STOCK EXCHANGE RELEASE 6 May 2024 at 2.00 p.m. EEST Jesper Blomster appointed as new CFO and member of the management team in Verkkokauppa.com Oyj MSc. (econ) Jesper Blomster (37) has been appointed as Chief Financial Officer (CFO) and a member of the management team in Verkkokauppa.com Oyj as of May 7, 2024. Blomster joins Verkkokauppa.com from Fiskars, where he has worked as SVP Finance and in other finance positions. Before Fiskars, he held various key finance positions, e.g. in Peak Performance, Kemira and Amer Sports. Current CFO Mikko Forsell will not continue working for Verkkokauppa.com. “I am very happy about the opportunity to start at Verkkokauppa.com. The company has progressed to an interesting stage on its journey, and I look forward to bringing my own know-how and experience to use for developing...

Boussard & Gavaudan Investment Management LLP: Form 8.3 –

Written by Customer Service on May 6, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Boussard & Gavaudan Investment Management LLP Boussard & Gavaudan Gestion SAS acting on behalf of various funds(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Network International Holdings PLC(d) If an exempt fund manager connected...

BioNTech Announces First Quarter 2024 Financial Results and Corporate Update

Written by Customer Service on May 6, 2024. Posted in Earnings Releases And Operating Results.

Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase 3 clinical trial evaluating BNT323/DB-1303 in HR+ HER2-low chemotherapy-naïve metastatic breast cancer patients, and a second Phase 3 trial with BNT323/DB-1303 in recurrent endometrial cancer planned to start soon Presented clinical data at the American Association for Cancer Research (“AACR”) Annual Meeting for individualized and off-the-shelf mRNA-based cancer vaccine candidates based on iNeST and FixVac platforms, including three-year follow-up data of an investigator-initiated trial in patients with resected pancreatic ductal adenocarcinoma (“PDAC”) Planning to share additional clinical data from multiple clinical programs at the American Society of Clinical Oncology (“ASCO”) Annual Meeting, including bispecific...

Day: May 6, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals